Hot Features
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral an... Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0075 | -6.52173913043 | 0.115 | 0.12 | 0.1 | 3286505 | 0.11008018 | DE |
| 4 | -0.0475 | -30.6451612903 | 0.155 | 0.16 | 0.1 | 4627758 | 0.12702501 | DE |
| 12 | -0.1925 | -64.1666666667 | 0.3 | 0.3 | 0.1 | 5096246 | 0.17665369 | DE |
| 26 | -0.1325 | -55.2083333333 | 0.24 | 0.33 | 0.1 | 4471519 | 0.21753812 | DE |
| 52 | 0.0785 | 270.689655172 | 0.029 | 0.33 | 0.026 | 5121346 | 0.16749683 | DE |
| 156 | 0.0925 | 616.666666667 | 0.015 | 0.33 | 0.01 | 5656051 | 0.10397111 | DE |
| 260 | -1.3925 | -92.8333333333 | 1.5 | 1.5 | 0.01 | 3738369 | 0.11285016 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.